share_log

HC Wainwright & Co. Reiterates Buy on Marinus Pharma, Maintains $27 Price Target

Moomoo 24/7 ·  Mar 6 07:38

HC Wainwright & Co. analyst Douglas Tsao reiterates Marinus Pharma (NASDAQ:MRNS) with a Buy and maintains $27 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment